CASIF (CASIF) Stock Price & Analysis
CASIF (CASIF) rose 0.00% to USD 0.13 as of July 25, 2026 at 06:11 UTC, according to Nexqual real-time market data.
CASIF last closed at USD 0.13; the session ranged USD 0.13–0.13 on volume of 18 shares. Market capitalization is $2.67M, with a 52-week range of USD 0.05–3.09 (OQB). Source: Nexqual, July 25, 2026 at 06:11 UTC.
Key Statistics (as of July 25, 2026 at 06:11 UTC)
| Price | USD 0.13 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0.13 |
| Open | USD 0.13 |
| Day Range | USD 0.13 – 0.13 |
| 52-Week Range | USD 0.05 – 3.09 |
| Volume | 18 shares |
| Market Cap | $2.67M |
| Exchange | OQB |
Technical Analysis (CASIF)
Nexqual's technical model rates CASIF "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 06:11 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 47.76 (neutral) |
| vs SMA50 | Below (USD 0.14) |
| MACD | -0 (negative) |
Analyst Ratings (CASIF)
Wall Street analysts rate CASIF "None", per Nexqual as of July 25, 2026 at 06:11 UTC.
| Consensus Rating | None |
|---|
Earnings (CASIF)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2025-12-31 | USD -0.36 vs est -0.36 ▲ beat |
| 2025-09-30 | USD -0.67 vs est -0.4 ▼ miss |
| 2025-06-30 | USD -0.86 vs est -0.47 ▼ miss |
| 2025-03-31 | USD -0.69 vs est -0.61 ▼ miss |
Source: Nexqual, July 25, 2026 at 06:11 UTC.
Financials & Fundamentals (CASIF)
| Total Revenue | $20.71M |
|---|---|
| Revenue Growth (YoY) | -45.90% |
| Gross Margin | +48.65% |
| Operating Margin | -161.37% |
| Profit Margin | -232.03% |
| Current Ratio | 0.27 |
| Total Cash | $5.63M |
| Total Debt | $27.49M |
| Free Cash Flow | $-650,750 |
Source: Nexqual, July 25, 2026 at 06:11 UTC.
Financial Health Score (CASIF)
Nexqual rates CASIF's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 06:11 UTC.
| Growth | Critical — Revenue -46% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $6M cash vs $27M debt |
| Cash Flow | Weak — FCF negative: -$651K, burning cash |
| Efficiency | Mixed — No data |
Ownership (CASIF)
| Insider Ownership | +45.31% |
|---|---|
| Institutional Ownership | +26.50% |
| Shares Outstanding | 20.56M |
| Float | 9.72M |
| Short % of Float | +0.54% |
Source: Nexqual, July 25, 2026 at 06:11 UTC.
Leadership (CASIF)
CASIF is led by Wei-Wu He (age 60), Executive Chairman of the Board & Principal Executive Officer, per Nexqual as of July 25, 2026 at 06:11 UTC.
| Executive Chairman of the Board & Principal Executive Officer | Wei-Wu He (age 60) |
|---|---|
| Chief Operating Officer | Chunhua Wang (age 53) |
| Senior Vice President | Wei Zhang (age 66) |
Major Backers & Investors (CASIF)
Notable institutional backers of CASIF include Fidelity, according to Nexqual as of July 25, 2026 at 06:11 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Fidelity | 0.15% |
Source: Nexqual, July 25, 2026 at 06:11 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CRIS | Curis, Inc. | USD 4.89 | ▼ 1.01% |
| BGMSP | Bio Green Med Solution Inc. | USD 3.5 | ▲ 0% |
| AGEN | Agenus Inc. | USD 5.98 | ▲ 8.14% |
| BIOM | Biomolecular Life Holdings, Inc. | USD 0.46 | ▲ 0% |
| CSCID | COSCIENS Biopharma Inc | USD 5.5 | ▲ 1.85% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 06:11 UTC. This page is informational and not investment advice.